#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	756	CRP	633	633	99.53	CRP.l15.c17.ctg.1	1280	43.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	404	406	ACG	45;45;45	A;C;G	45;45;45	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2600	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1739	108.2	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1547	1549	AGC	70;73;73	A,G;G;C	40,30;73;73	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2600	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1739	108.2	0	HET	.	.	.	C99T	.	99	99	C	466	466	C	116	C,T	62,52	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2600	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1739	108.2	0	HET	.	.	.	C954T	.	954	954	C	1321	1321	C	117	C,T	56,59	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2600	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1739	108.2	0	HET	.	.	.	T135C	.	135	135	T	502	502	T	126	T,C	66,59	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	667	2600	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1739	108.2	0	HET	.	.	.	C216T	.	216	216	C	583	583	C	159	C,T	92,66	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1200	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	2027	43.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1653	1655	AAA	50;49;49	A;A;A	50;49;49	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1554	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c30.ctg.1	1972	58.1	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1334	1336	GAA	102;104;106	G;A;A	102;104;106	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	350	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	1086	23.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	245	G	244	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	248	C	246	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	237	C	235	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	331	T	328	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	379	C,A	376,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	306	C	301	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	262	A	261	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	253	A	249	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	240	A	239	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	228	T	222	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	224	C	219	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	221	C	221	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	221	A	220	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	237	G	235	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	240	C	239	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	243	T	241	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	271	G	267	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	270	G	267	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	271	T	269	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	344	T	343	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	338	G,C	337,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	328	C	326	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	319	A	315	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	226	C	225	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	200	C	198	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	135	A	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	142	A	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	189	G	188	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	174	C	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	234	T	234	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	242	G	241	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	235	T	233	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	836	187.4	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	397	C	396	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	179	92.74	Pasteurella_multocida_16S.l15.c30.ctg.3	179	65.7	0	.	n	.	0	C990G	SNP	990	990	C	54	54	G	69	G	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	179	92.74	Pasteurella_multocida_16S.l15.c30.ctg.3	179	65.7	0	.	n	.	0	T1002A	SNP	1002	1002	T	66	66	A	71	A	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	179	92.74	Pasteurella_multocida_16S.l15.c30.ctg.3	179	65.7	0	.	n	.	0	A1004G	SNP	1004	1004	A	68	68	G	71	G	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	179	92.74	Pasteurella_multocida_16S.l15.c30.ctg.3	179	65.7	0	.	n	.	0	C1011T	SNP	1011	1011	C	75	75	T	72	T	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	179	92.74	Pasteurella_multocida_16S.l15.c30.ctg.3	179	65.7	0	.	n	.	0	C1023A	SNP	1023	1023	C	87	87	A	92	A	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	179	92.74	Pasteurella_multocida_16S.l15.c30.ctg.3	179	65.7	0	.	n	.	0	T1024A	SNP	1024	1024	T	88	88	A	93	A	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	179	92.74	Pasteurella_multocida_16S.l15.c30.ctg.3	179	65.7	0	.	n	.	0	T1041G	SNP	1041	1041	T	105	105	G	89	G	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	179	92.74	Pasteurella_multocida_16S.l15.c30.ctg.3	179	65.7	0	.	n	.	0	A1042T	SNP	1042	1042	A	106	106	T	88	T	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	C990G	SNP	990	990	C	60	60	G	70	G	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	T1002A	SNP	1002	1002	T	72	72	A	53	A	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	A1003C	SNP	1003	1003	A	73	73	C	47	C	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	G1008C	SNP	1008	1008	G	78	78	C	45	C	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	C1011T	SNP	1011	1011	C	81	81	T	46	T	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	T1012C	SNP	1012	1012	T	82	82	C	47	C	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	C1023A	SNP	1023	1023	C	92	92	A	52	A	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	.1025G	INS	1025	1025	T	95	95	G	58	G	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	T1041G	SNP	1041	1041	T	111	111	G	72	G	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	.	n	.	0	A1042T	SNP	1042	1042	A	112	112	T	73	T	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	3874	Pasteurella_multocida_16S	1551	184	92.43	Pasteurella_multocida_16S.l15.c30.ctg.5	184	76.7	0	HET	.	.	.	G1005A	.	1005	1005	G	75	75	G	46	G,A	30,16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	990	PmrB_1	1092	1092	99.18	PmrB_1.l15.c30.ctg.1	1754	41.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	387	389	CGT	45;47;47	C;G;T	45;46;46	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	990	PmrB_1	1092	1092	99.18	PmrB_1.l15.c30.ctg.1	1754	41.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1230	1232	GGC	55;54;55	G;G;C	55;54;55	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1616	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2170	55.1	0	.	p	.	0	R8S	NONSYN	22	24	AGA	317	319	AGC	31;31;32	A;G;C	31;31;32	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1616	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2170	55.1	0	.	p	.	0	I142L	NONSYN	424	426	ATA	719	721	CTA	53;53;53	C;T;A	52;52;53	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1616	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2170	55.1	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1238	1240	CAA	69;72;71	C;A;A	69;72;71	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1616	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2170	55.1	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1337	1339	GGT	84;83;83	G;G;T	84;83;83	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1616	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2170	55.1	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1907	1909	GTT	44;43;44	G;T;T	44;43;44	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	734	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1882	29.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	801	803	GAA	44;43;40	G;A;A	44;43;40	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	734	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1882	29.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	981	983	ACC	34;33;34	A;C;C	34;33;34	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	734	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1882	29.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	1101	1103	ACT	25;26;26	A;C;T	25;26;26	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	734	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1882	29.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1491	1493	ATC	22;22;22	A;T;C	22;22;22	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	994	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1524	48.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_1.3000873.AL513383.161910_162771.1951	TEM_1.3000873.AL513383.161910_162771.1951	1	0	155	2978	TEM_1+	861	861	99.88	TEM_1+.l15.c30.ctg.1	1451	150.1	0	HET	.	.	.	A138G	.	138	138	A	443	443	A	215	A,G	184,31	.	TEM-1;TEM-1 is a broad-spectrum beta-lactamase found in many Gram-negative bacteria.
TEM_1.3000873.AL513383.161910_162771.1951	TEM_1.3000873.AL513383.161910_162771.1951	1	0	155	2978	TEM_1+	861	861	99.88	TEM_1+.l15.c30.ctg.1	1451	150.1	0	HET	.	.	.	T474C	.	474	474	T	779	779	T	246	T,C	212,31	.	TEM-1;TEM-1 is a broad-spectrum beta-lactamase found in many Gram-negative bacteria.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2962	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3614	60.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	522	524	ATC	68;69;70	A,G;T;C	67,1;69;70	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2962	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3614	60.5	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2235	2237	AAG	56;57;58	A;A;G	56;57;58	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1166	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1688	51.3	0	.	p	.	0	A22V	NONSYN	64	66	GCC	313	315	GTC	33;33;32	G;T;C	33;33;32	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1166	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1688	51.3	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1054	1056	TGC	70;69;69	T;G;C	70;69;69	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2960	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3675	59.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	484	484	T	56	T	56	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2960	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3675	59.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	790	792	GAC	55;53;54	G;A;C	55;53;53	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2960	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3675	59.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1066	1068	TTA	41;41;39	T;T;A	41;41;39	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2960	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3675	59.5	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2143	2145	AAT	71;70;70	A;A;T	71;70;70	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2960	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3675	59.5	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2257	2259	AGT	68;65;66	A;G;T	67;64;65	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2960	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3675	59.5	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2656	2658	GTG	47;51;50	G;T;G	47;50;50	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2960	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3675	59.5	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3211	3213	AAG	63;63;64	A;A;G	63;63;64	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	598	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1304	34.0	1	SNP	p	R45C	0	.	.	133	135	CGC	501	503	CGC	59;58;56	C;G;C	59;58;56	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	546	acrS	663	663	98.79	acrS.l15.c4.ctg.1	1216	33.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	288	290	TTC	48;46;45	T;T;C	47;46;45	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	546	acrS	663	663	98.79	acrS.l15.c4.ctg.1	1216	33.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	552	554	GGG	56;54;54	G;G;G	56;54;54	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	612	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1427	31.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	658	660	CTT	43;44;44	C;T;T	43;44;44	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2790	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3192	64.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2059	2061	GCA	77;77;76	G;C;A	77;77;76	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2790	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3192	64.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2320	2322	ACC	72;72;73	A;C;C	72;72;73	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2790	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3192	64.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2629	2631	GCC	100;96;95	G;C;C	99;95;94	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1520	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2592	43.4	0	.	p	.	0	G37A	NONSYN	109	111	GGT	364	366	GCT	29;29;29	G;C;T	29;29;29	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1520	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2592	43.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	484	486	GAG	29;31;30	G;A;G	29;31;30	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1520	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2592	43.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	520	522	TGC	48;48;49	T;G;C	48;47;49	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1520	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2592	43.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	703	705	GTT	51;52;54	G;T;T	49;51;52	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1520	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2592	43.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	853	855	CAC	51;50;51	C;A;C	50;49;50	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1520	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2592	43.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1138	1140	ATG	90;90;87	A;T;G	89;87;85	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1520	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2592	43.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2134	2136	CGC	57;54;53	C;G;C	57;53;53	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	816	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1445	42.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	975	977	ACC	59;59;59	A;C;C	59;58;58	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	816	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1445	42.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	987	989	TCG	63;64;66	T;C;G	62;64;66	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	682	baeR	723	723	97.79	baeR.l6.c30.ctg.1	1550	32.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1014	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2075	36.2	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1412	1414	AAA	26;27;27	A;A;A	26;27;27	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1014	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2075	36.2	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1424	1426	GAG	22;22;22	G;A;G	22;22;22	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1014	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2075	36.2	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1430	1432	CAC	22;23;23	C;A;C	22;23;23	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1014	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	2075	36.2	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1484	1486	GAG	36;36;36	G;A;G	36;36;34	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1282	cpxA	1374	1374	98.91	cpxA.l6.c30.ctg.1	2029	47.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	770	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1423	40.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	752	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1563	36.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	980	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1884	38.6	0	.	p	.	0	W42C	NONSYN	124	126	TGG	432	434	TGT	33;34;34	T;G;T	33;34;34	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	980	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1884	38.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	963	965	GTC	81;79;80	G;T;C	81;79;79	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1626	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	2198	55.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1256	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1717	54.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	869	871	AGC	70;69;69	A;G;C,T	70;69;68,1	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	531	52	emrE_1	333	321	92.83	emrE_1.l15.c4.ctg.1	345	9.5	0	.	p	.	0	I100V	NONSYN	298	300	ATT	319	321	GTC	2;2;1	G;T;C	2;2;1	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	728	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1578	33.7	0	.	p	.	0	K176R	NONSYN	526	528	AAG	742	744	AGG	34;35;34	A;G;G	33;34;33	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	728	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1578	33.7	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1132	1134	GAC	43;43;44	G;A;C	43;43;44	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	638	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1174	40.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1124	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2270	36.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	414	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1097	28.0	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	435	437	CTG	43;41;40	C;TGG,TG;G	42;36,1;39	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	T38I	NONSYN	112	114	ACA	399	401	ATA	25;24;24	A;T;A	25;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	L42V	NONSYN	124	126	CTA	411	413	GTA	20;19;19	G;T;A	19;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	A93T	NONSYN	277	279	GCG	564	566	ACG	40;40;39	A;C;G	40;40;39	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	A114E	NONSYN	340	342	GCA	627	629	GAA	35;35;36	G;A;A	35;35;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	T127A	NONSYN	379	381	ACT	666	668	GCT	34;34;31	G;C;T	34;34;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	N133D	NONSYN	397	399	AAT	684	686	GAT	26;25;25	G;A;T	26;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	P162S	NONSYN	484	486	CCA	771	773	TCA	23;22;22	T;C;A	23;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	900	902	CAG	37;38;38	C;A;G	37;38;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1038	1040	GTT	32;34;34	G,C;T;T	31,1;34;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1194	1196	GAT	22;23;24	G;A;T	22;23;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1362	1364	AAT	23;23;23	A;A;T	23;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1383	1385	TTA	20;21;22	T;T;A	20;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1584	1586	AAA	21;23;24	A;A;A	21;23;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2319	2321	CAT	36;35;35	C;A;T,G	36;35;34,1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2373	2375	CAT	31;31;31	C;A,G;T	31;30,1;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2391	2393	AGA	30;29;29	A;G;A	30;29;29	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2406	2408	AAT	34;34;34	A;A;T	34;34;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2553	2555	TCC	45;44;43	T;C;C	45;44;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2718	2720	ATT	34;33;33	A;T;T	34;33;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2739	2741	GAT	39;39;38	G;A;T	39;39;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2853	2855	GTT	43;42;41	G;T;T	43;42;41	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2114	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4172	37.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3138	3140	CAC	60;59;58	C;A;C	59;59;58	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	734	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1565	34.3	1	SNP	p	P64H	0	.	.	190	192	CCA	495	497	CCA	61;60;62	C;C;A	60;59;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	734	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1565	34.3	1	SNP	p	P64L	0	.	.	190	192	CCA	495	497	CCA	61;60;62	C;C;A	60;59;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	734	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1565	34.3	1	SNP	p	P64A	0	.	.	190	192	CCA	495	497	CCA	61;60;62	C;C;A	60;59;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	734	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1565	34.3	1	SNP	p	P64R	0	.	.	190	192	CCA	495	497	CCA	61;60;62	C;C;A	60;59;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	734	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1565	34.3	1	SNP	p	P64S	0	.	.	190	192	CCA	495	497	CCA	61;60;62	C;C;A	60;59;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	422	gadE	528	528	100.0	gadE.l6.c30.ctg.1	1228	25.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	H17Y	NONSYN	49	51	CAT	4	6	TAT	1;1;1	T;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	Q21H	NONSYN	61	63	CAA	16	18	CAT	1;1;1	C;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	L31V	NONSYN	91	93	CTG	46	48	GTG	1;1;1	G;T;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	D34E	NONSYN	100	102	GAT	55	57	GAG	1;1;1	G;A;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	L46P	NONSYN	136	138	CTG	91	93	CCG	3;3;3	C;C;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	E54D	NONSYN	160	162	GAA	115	117	GAT	3;4;4	G;A;T	3;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	I88M	NONSYN	262	264	ATA	217	219	ATG	6;6;5	A;T,G;G	5;5,1;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	220	222	CCG	5;5;5	C;C;G	5;4;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	D100E	NONSYN	298	300	GAC	253	255	GAA	4;4;4	G;A;A	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	P101S	NONSYN	301	303	CCC	256	258	TCC	4;4;4	T;C;C	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	R102G	NONSYN	304	306	CGG	259	261	GGG	4;4;4	G;G;G	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	K110N	NONSYN	328	330	AAA	283	285	AAT	6;6;6	A;A;T	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	140	gadW	729	729	94.15	gadW.l15.c30.ctg.1	810	12.5	0	.	p	.	0	S234A	NONSYN	700	702	TCG	655	657	GCG	12;12;12	G;C;G	12;12;12	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	528	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1410	27.8	0	.	p	.	0	F53L	NONSYN	157	159	TTC	446	448	TTA	47;47;47	T;T;A	47;47;47	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	528	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1410	27.8	0	.	p	.	0	V79I	NONSYN	235	237	GTT	524	526	ATT	48;47;48	A;T;T	47;47;48	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	528	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1410	27.8	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1025	1027	GGA	25;24;24	G;G;A	25;24;24	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	528	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1410	27.8	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1031	1033	CCG	27;27;27	C;C;G	27;26;26	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2380	2382	GAA	75;76;75	G;A;A	74;74;74	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	1	SNP	p	S83W	0	.	.	247	249	TCG	595	597	TCG	73;73;72	T;C;G	73;73;72	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	1	SNP	p	S83L	0	.	.	247	249	TCG	595	597	TCG	73;73;72	T;C;G	73;73;72	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	1	SNP	p	S83I	0	.	.	247	249	TCG	595	597	TCG	73;73;72	T;C;G	73;73;72	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	1	SNP	p	D87V	0	.	.	259	261	GAC	607	609	GAC	70;70;69	G;A,G;C	69;69,1;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	1	SNP	p	D87G	0	.	.	259	261	GAC	607	609	GAC	70;70;69	G;A,G;C	69;69,1;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	1	SNP	p	D87N	0	.	.	259	261	GAC	607	609	GAC	70;70;69	G;A,G;C	69;69,1;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	607	609	GAC	70;70;69	G;A,G;C	69;69,1;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2600	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3285	58.6	1	SNP	p	D87H	0	.	.	259	261	GAC	607	609	GAC	70;70;69	G;A,G;C	69;69,1;69	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2378	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	3155	56.1	1	SNP	p	R136L	0	.	.	406	408	CGC	761	763	CGC	72;72;72	C;G;C	72;72;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2378	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	3155	56.1	1	SNP	p	R136I	0	.	.	406	408	CGC	761	763	CGC	72;72;72	C;G;C	72;72;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2378	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	3155	56.1	1	SNP	p	R136H	0	.	.	406	408	CGC	761	763	CGC	72;72;72	C;G;C	72;72;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2378	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	3155	56.1	1	SNP	p	R136E	0	.	.	406	408	CGC	761	763	CGC	72;72;72	C;G;C	72;72;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2378	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	3155	56.1	1	SNP	p	R136C	0	.	.	406	408	CGC	761	763	CGC	72;72;72	C;G;C	72;72;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2378	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	3155	56.1	1	SNP	p	R136G	0	.	.	406	408	CGC	761	763	CGC	72;72;72	C;G;C	72;72;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2378	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	3155	56.1	1	SNP	p	R136S	0	.	.	406	408	CGC	761	763	CGC	72;72;72	C;G;C	72;72;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	488	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1235	29.0	0	.	p	.	0	A72P	NONSYN	214	216	GCG	508	510	CCG	51;52;49	C;C;G	48;51;48	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	488	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1235	29.0	0	.	p	.	0	T123A	NONSYN	367	369	ACC	661	663	GCC	36;36;37	G;C;C	36;36;37	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	770	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1588	35.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	298	300	TCA	45;46;47	T;C;A	43;44;45	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	336	marA	384	384	99.74	marA.l15.c30.ctg.1	1157	21.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	660	662	AGC	24;24;23	A;G;C	24;24;23	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	762	764	CAT	25;24;24	C;A;T	25;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	V45E	0	.	.	133	135	GTG	486	488	GTG	55;54;54	G;T;G	55;54;54	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	I49S	0	.	.	145	147	ATC	498	500	ATC	61;63;64	A;T;C	61;62;64	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	A70T	0	.	.	208	210	GCA	561	563	GCA	35;36;36	G;C;A	35;36;36	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	R73C	0	.	.	217	219	CGT	570	572	CGT	32;33;31	C;G;T	32;33;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	R73S	0	.	.	217	219	CGT	570	572	CGT	32;33;31	C;G;T	32;33;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	R77L	0	.	.	229	231	CGC	582	584	CGC	28;26;27	C;G;C	28;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	R77C	0	.	.	229	231	CGC	582	584	CGC	28;26;27	C;G;C	28;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	L78M	0	.	.	232	234	CTG	585	587	CTG	27;28;28	C;T;G	26;28;28	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	R94H	0	.	.	280	282	CGC	633	635	CGC	30;29;30	C;G;C	30;29;30	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	R94S	0	.	.	280	282	CGC	633	635	CGC	30;29;30	C;G;C	30;29;30	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	308	marR	435	435	97.7	marR.l15.c4.ctg.1	982	23.0	1	SNP	p	V96E	0	.	.	286	288	GTA	639	641	GTA	30;30;30	G;T;A	30;30;30	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	916	mdfA	1233	1233	96.67	mdfA.l6.c30.ctg.1	1742	38.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	267	269	TTC	29;30;31	T;T;C	29;30;31	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	916	mdfA	1233	1233	96.67	mdfA.l6.c30.ctg.1	1742	38.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	354	356	ATC	20;20;20	A;T;C	20;20;20	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	916	mdfA	1233	1233	96.67	mdfA.l6.c30.ctg.1	1742	38.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	372	374	GCC	19;19;20	G;C;C	19;19;20	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	916	mdfA	1233	1233	96.67	mdfA.l6.c30.ctg.1	1742	38.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	375	377	GTG	20;21;21	G;T;G	20;21;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	916	mdfA	1233	1233	96.67	mdfA.l6.c30.ctg.1	1742	38.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	402	404	GAT	24;23;24	G;A;T	23;23;24	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	916	mdfA	1233	1233	96.67	mdfA.l6.c30.ctg.1	1742	38.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	423	425	ACC	28;27;27	A;C;C	28;27;27	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	916	mdfA	1233	1233	96.67	mdfA.l6.c30.ctg.1	1742	38.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	450	452	TTA	29;29;28	T;T;A	29;29;28	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	916	mdfA	1233	1233	96.67	mdfA.l6.c30.ctg.1	1742	38.9	0	.	p	.	0	G88fs	FSHIFT	262	262	G	510	510	G	38	G	38	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1859	31.8	0	.	p	.	0	V12trunc	TRUNC	34	34	G	269	269	G	17	G	17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1859	31.8	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	326	328	CAG	12;12;11	C;A;G	12;12;11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1859	31.8	0	.	p	.	0	T83I	NONSYN	247	249	ACC	476	478	ATC	25;25;24	A;T;C	25;25;24	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1859	31.8	0	.	p	.	0	I99M	NONSYN	295	297	ATA	524	526	ATG	17;18;19	A;T;G	17;18;19	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1859	31.8	0	.	p	.	0	A130T	NONSYN	388	390	GCC	617	619	ACC	34;34;34	A;C;C	34;33;34	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2888	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3647	58.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2038	2040	ACC	91;90;89	A;C;C	91;89;89	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2888	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3647	58.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2431	2433	CAA	60;58;61	C;A;A	60;58;61	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2888	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3647	58.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2599	2601	ATT	48;50;51	A;T;T	48;50;51	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2888	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3647	58.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2683	2685	GTT	45;43;42	G;T;T	45;42;42	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2888	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3647	58.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2791	2793	GAG	43;40;39	G;A;G	42;39;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2888	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3647	58.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3019	3021	ATG	54;55;55	A;T;G	54;55;54	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2888	mdtB	3123	3123	98.94	mdtB.l6.c4.ctg.1	3647	58.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3154	3156	GAT	71;72;72	G;A;T	71;71;71	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2682	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3868	51.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	510	512	ATG	30;29;30	A;T;G	29;29;29	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2682	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3868	51.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	996	998	ATC	62;63;64	A;T;C	62;62;63	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2682	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3868	51.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3312	3314	CAC	33;32;32	C;A;C	33;32;31	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1284	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2083	45.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	310	312	GAA	23;24;24	G;A;A	23;24;24	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1284	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2083	45.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	979	981	GCG	59;61;62	G;C;G	59;61;62	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1284	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2083	45.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1321	1323	ATC	74;74;75	A;T;C	74;74;75	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1284	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2083	45.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1624	1626	TTT	43;44;44	T;T;T	43;44;44	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1296	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1816	53.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	795	3032	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3792	59.3	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1189	1191	ACC	62;60;59	A;C,T;C	62;59,1;59	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	795	3032	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3792	59.3	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2431	2433	GAC	68;69;69	G;A;C	68;68;69	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1046	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1753	37.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	671	673	ATC	53;54;53	A;T;C	52;53;52	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1046	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	721	16.5	0	.	p	.	0	E5G	NONSYN	13	15	GAA	220	222	GGA	19;19;18	G;G;A	18;18;17	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1020	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1731	44.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	667	669	TGT	48;48;49	T;G;T	48;48;49	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1020	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1731	44.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1237	1239	TTG	50;50;50	T;T;G	50;50;50	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1020	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1731	44.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1447	1449	ACG	28;28;28	A;C;G	28;28;28	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1284	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1933	49.4	0	.	p	.	0	A185S	NONSYN	553	555	GCC	999	1001	TCC	42;42;42	T;C;C	42;42;42	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	892	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1732	38.5	0	.	p	.	0	V119I	NONSYN	355	357	GTT	740	742	ATT	68;68;69	A;T;T	68;68;69	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	V11M	NONSYN	31	33	GTG	248	250	ATG	40;40;40	A;T;G	40;40;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	T33I	NONSYN	97	99	ACC	314	316	ATC	27;27;27	A;T;C	26;25;27	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	C116R	NONSYN	346	348	TGC	563	565	CGC	74;76;77	C;G;C	74;76;77	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	N238S	NONSYN	712	714	AAC	929	931	AGC	42;42;43	A;G,T;C	41;40,1;43	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1130	1132	GTG	53;51;51	G,A;T;G	52,1;51;51	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1193	1195	AAC	37;38;39	A;A,C;C	34;29,1;36	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1238	1240	GTC	50;50;51	G;T;C	49;49;50	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1268	1270	ATA	59;59;59	A;T;A	59;58;57	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1376	1378	TCT	48;49;50	T;C;T	48;49;49	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1763	1765	GCG	59;60;62	G;C;G	58;59;61	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1842	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2573	53.2	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1976	1978	ATC	62;62;61	A;T;C	62;62;61	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	606	606	T	76	T	76	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	789	791	GCG	51;51;50	G;C;G	51;51;50	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	963	965	ACC	75;75;72	A;C;C	74;74;71	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	1035	1037	CGC	74;73;76	C;G;C	74;73;76	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1152	1154	GCT	63;63;63	G;C;T	62;63;63	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1236	1238	AAA	62;62;61	A;A;A	60;60;60	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1254	1256	CGA	52;52;51	C;G;A	52;52;51	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1419	1421	GCC	47;47;47	G;C;C	47;47;47	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1431	1433	GAT	45;44;44	G;A;T	45;44;44	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1310	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2152	45.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1848	1850	GCT	26;26;26	G;C;T	26;26;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3056	mfd	3447	3447	99.13	mfd.l15.c30.ctg.1	4018	56.8	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1548	1550	AAG	43;44;43	A;A;G	43;44;43	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3056	mfd	3447	3447	99.13	mfd.l15.c30.ctg.1	4018	56.8	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2625	2627	CTG	48;48;45	C;T;G	48;48;44	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3056	mfd	3447	3447	99.13	mfd.l15.c30.ctg.1	4018	56.8	0	.	p	.	0	A1033V	NONSYN	3097	3099	GCC	3336	3338	GTC	55;55;53	G;T;C	55;55;53	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	262	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	872	22.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1622	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2314	51.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1108	1110	AAC	67;66;67	A;A;C	67;66;67	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1622	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2314	51.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1654	1656	ATA	76;74;74	A;T;A	74;73;74	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1508	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1986	56.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1430	1432	GAT	97;96;99	G;A;T	97;96;99	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1508	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1986	56.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1433	1435	CTG	100;101;99	C;T;G	100;101;98	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	608	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1367	32.3	0	.	p	.	0	R27C	NONSYN	79	81	CGT	377	379	TGT	53;55;58	T;G;T	53;55;58	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	608	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1367	32.3	0	.	p	.	0	I117T	NONSYN	349	351	ATC	647	649	ACC	45;45;44	A;C;C	45;45;44	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	608	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1367	32.3	0	.	p	.	0	G187D	NONSYN	559	561	GGC	857	859	GAC	40;40;41	G;A;C	39;39;40	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	608	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1367	32.3	1	SNP	p	R15C	0	.	.	43	45	CGC	341	343	CGC	62;61;61	C,G;G;C	61,1;61;60	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	608	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1367	32.3	1	SNP	p	S33R	0	.	.	97	99	AGC	395	397	AGC	69;69;69	A;G;C	69;69;69	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	608	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1367	32.3	1	SNP	p	G131D	0	.	.	391	393	GGC	689	691	GGC	55;53;53	G;G;C	55;53;53	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	608	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1367	32.3	1	SNP	p	R203C	0	.	.	607	609	CGT	905	907	CGT	42;43;44	C;G;T	42;43;44	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	608	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1367	32.3	1	SNP	p	R203L	0	.	.	607	609	CGT	905	907	CGT	42;43;44	C;G;T	42;43;44	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1136	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1615	51.8	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1114	1116	GAG	65;65;64	G;A;G	64;65;64	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1136	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1615	51.8	1	SNP	p	G141D	0	.	.	421	423	GGT	601	603	GGT	82;82;82	G;G;T	82;81;81	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1136	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1615	51.8	1	SNP	p	G141E	0	.	.	421	423	GGT	601	603	GGT	82;82;82	G;G;T	82;81;81	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1136	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1615	51.8	1	SNP	p	R154A	0	.	.	460	462	CGT	640	642	CGT	92;94;96	C;G;T	91;93;95	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1136	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1615	51.8	1	SNP	p	R154D	0	.	.	460	462	CGT	640	642	CGT	92;94;96	C;G;T	91;93;95	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2336	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2979	57.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1984	1986	TCG	78;78;79	T;C;G	76;77;78	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2336	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2979	57.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2599	2601	AAC	46;46;47	A;A;C	46;46;46	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2336	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2979	57.7	1	SNP	p	A85T	0	.	.	253	255	GCG	613	615	GCG	74;74;73	G;C;G	74;74;72	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2336	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2979	57.7	1	SNP	p	D111H	0	.	.	331	333	GAT	691	693	GAT	63;64;62	G;A;T	63;62;61	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2336	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2979	57.7	1	SNP	p	S129P	0	.	.	385	387	TCC	745	747	TCC	60;62;62	T;C;C	60;62;62	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1608	parE_1	1893	1893	97.52	parE_1.l6.c4.ctg.1	2622	45.6	0	.	p	.	0	D476A	NONSYN	1426	1428	GAT	1738	1740	GCT	69;69;69	G;C;T	69;69;69	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1402	patA	1380	1380	99.86	patA.l15.c30.ctg.1	2112	49.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1407	1409	GAT	67;69;69	G;A;T	67;69;69	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	V146F	0	.	.	436	438	GTT	779	781	GTT	72;71;75	G;T;T	72;71;75	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1880	1882	CAG	72;72;71	C;A;G	72;72;71	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1880	1882	CAG	72;72;71	C;A;G	72;72;71	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1919	1921	CAC	60;59;60	C;A;C	59;58;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1928	1930	CGT	61;62;65	C;G;T	61;62;65	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1928	1930	CGT	61;62;65	C;G;T	61;62;65	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1934	1936	TCC	64;64;64	T;C;C	64;64;64	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1940	1942	CTC	67;66;65	C;T;C	67;66;64	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	2030	2032	ACC	70;71;70	A;C;C	70;71;69	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	2033	2035	CCT	69;70;70	C;C;T	69;70;70	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4002	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4634	64.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2402	2404	CGT	106;105;106	C;G;T	106;103;106	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	.	n	.	0	A226G	SNP	226	226	A	367	367	G	560	G,C	559,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	1	SNP	n	A794T	0	.	.	794	794	A	935	935	A	586	A	576	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	1	SNP	n	A794G	0	.	.	794	794	A	935	935	A	586	A	576	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	1	SNP	n	G926A	0	.	.	926	926	G	1067	1067	G	525	G,T	524,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	1	SNP	n	G926C	0	.	.	926	926	G	1067	1067	G	525	G,T	524,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	1	SNP	n	G926T	0	.	.	926	926	G	1067	1067	G	525	G,T	524,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	1660	1660	A	324	A	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	1660	1660	A	324	A	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	1660	1660	A	324	A	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	C719T,A	.	719	719	C	860	860	C	534	C,T,A	330,197,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	C183T	.	183	183	C	324	324	C	521	C,T	310,211	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	A250T	.	250	250	A	391	391	A	520	A,T	394,121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	T90C	.	90	90	T	231	231	T	548	T,C	406,140	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	G474A	.	474	474	G	615	615	G	524	G,A	404,115	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	A253T,G	.	253	253	A	394	394	A	520	A,T,G	393,121,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	C1038T	.	1038	1038	C	1179	1179	C	546	C,T	332,211	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	C194T	.	194	194	C	335	335	C	524	C,T	403,119	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	G1002A	.	1002	1002	G	1143	1143	G	506	G,A	327,179	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	G1003A	.	1003	1003	G	1144	1144	G	519	G,A	452,61	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	G1006C	.	1006	1006	G	1147	1147	G	516	G,C	329,178	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	A79G	.	79	79	A	220	220	A	583	A,G	426,154	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	T273A	.	273	273	T	414	414	T	538	T,A	406,124	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1696	512.3	0	HET	.	.	.	T1010C	.	1010	1010	T	1151	1151	T	513	T,C	320,185	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	686	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1149	44.6	1	SNP	p	R20H	0	.	.	58	60	CGC	478	480	CGC	73;70;73	C;G;C	73;70;73	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	686	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1149	44.6	1	SNP	p	G121D	0	.	.	361	363	GGT	781	783	GGT	75;73;71	G;G;T	75;73;71	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	440	soxS_1	324	324	99.69	soxS_1.l6.c30.ctg.1	1126	29.2	1	SNP	p	A12S	0	.	.	34	36	GCA	401	403	GCA	74;75;75	G;C;A,G	74;75;74,1	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	16	12	APH_3____Ib+	804	231	100.0	APH_3____Ib+.l6.c30.ctg.1	252	1.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1512	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2180	51.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
